RXR: From Partnership to Leadership in Metabolic Regulations

Vitamins and Hormones

Volumn 75, Issue , 2007, Pages 1-32

  Desvergne, Béatrice ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; HUMANS; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 33947103526     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(06)75001-4     Document Type: Review

References (178)

1. Altucci L., Rossin A., Hirsch O., Nebbioso A., Vitoux D., Wilhelm E., Guidez F., De Simone M., Schiavone E.M., Grimwade D., Zelent A., de The H., et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res. 65 19 (2005) 8754-8765
2. Ananthanarayanan M., Balasubramanian N., Makishima M., Mangelsdorf D.J., and Suchy F.J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276 31 (2001) 28857-28865
3. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 3 (2001) 1269-1304
4. Balasubramanian S., Chandraratna R.A., and Eckert R.L. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid. Carcinogenesis 25 8 (2004) 1377-1385
5. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 4 (1999) 585-595
6. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., and Evans R.M. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99 1 (2002) 303-308
7. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., and Kelly D.P. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J. Clin. Invest. 105 12 (2000) 1723-1730
8. Bastie C., Holst D., Gaillard D., Jehl-Pietri C., and Grimaldi P.A. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts. J. Biol. Chem. 274 31 (1999) 21920-21925
9. Bedu E., Wahli W., and Desvergne B. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases. Expert Opin. Ther. Targets 9 4 (2005) 861-873
10. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., and Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 5497 (2000) 1771-1775
11. Bocher V., Pineda-Torra I., Fruchart J.C., and Staels B. PPARs: Transcription factors controlling lipid and lipoprotein metabolism. Ann. NY Acad. Sci. 967 (2002) 7-18
12. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5 2 (2000) 289-298
13. Braissant O., Foufelle F., Scotto C., Dauça M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology 137 (1996) 354-366
14. Brelivet Y., Kammerer S., Rochel N., Poch O., and Moras D. Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level. EMBO Rep. 5 4 (2004) 423-429
15. Calleja C., Messaddeq N., Chapellier B., Yang H., Krezel W., Li M., Metzger D., Mascrez B., Ohta K., Kagechika H., Endo Y., Mark M., et al. Genetic and pharmacological evidence that a acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev. 20 11 (2006) 1525-1538
16. Cao G., Liang Y., Broderick C.L., Oldham B.A., Beyer T.P., Schmidt R.J., Zhang Y., Stayrook K.R., Suen C., Otto K.A., Miller A.R., Dai J., et al. Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 278 2 (2003) 1131-1136
17. Cao X., Liu W., Lin F., Li H., Kolluri S.K., Lin B., Han Y.H., Dawson M.I., and Zhang X.K. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 24 22 (2004) 9705-9725
18. Castillo A.I., Sanchez-Martinez R., Moreno J.L., Martinez-Iglesias O.A., Palacios D., and Aranda A. A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid. Mol. Cell. Biol. 24 2 (2004) 502-513
19. Cavasotto C.N., Liu G., James S.Y., Hobbs P.D., Peterson V.J., Bhattacharya A.A., Kolluri S.K., Zhang X.K., Leid M., Abagyan R., Liddington R.C., and Dawson M.I. Determinants of retinoid X receptor transcriptional antagonism. J. Med. Chem. 47 18 (2004) 4360-4372
20. Cesario R.M., Klausing K., Razzaghi H., Crombie D., Rungta D., Heyman R.A., and Lala D.S. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol. Endocrinol. 15 8 (2001) 1360-1369
21. Cha B.S., Ciaraldi T.P., Carter L., Nikoulina S.E., Mudaliar S., Mukherjee R., Paterniti Jr. J.R., and Henry R.R. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 44 4 (2001) 444-452
22. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
23. Chen G., Liang G., Ou J., Goldstein J.L., and Brown M.S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. USA 101 31 (2004) 11245-11250
24. Chen J.Y., Levy-Wilson B., Goodart S., and Cooper A.D. Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J. Biol. Chem. 277 45 (2002) 42588-42595
25. Chen Y., Wei L.N., and Muller J.D. Unraveling protein-protein interactions in living cells with fluorescence fluctuation brightness analysis. Biophys. J. 88 6 (2005) 4366-4377
26. Chen Z.P., Iyer J., Bourguet W., Held P., Mioskowski C., Lebeau L., Noy N., Chambon P., and Gronemeyer H. Ligand- and DNA-induced dissociation of RXR tetramers. J. Mol. Biol. 275 1 (1998) 55-65
27. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., Evans R.M., Schneider M.D., Brako F.A., Xiao Y., Chen Y.E., and Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10 11 (2004) 1245-1250
28. Claudel T., Leibowitz M.D., Fievet C., Tailleux A., Wagner B., Repa J.J., Torpier G., Lobaccaro J.M., Paterniti J.R., Mangelsdorf D.J., Heyman R.A., and Auwerx J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA 98 5 (2001) 2610-2615
29. Davies P.J., Berry S.A., Shipley G.L., Eckel R.H., Hennuyer N., Crombie D.L., Ogilvie K.M., Peinado-Onsurbe J., Fievet C., Leibowitz M.D., Heyman R.A., and Auwerx J. Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity. Mol. Pharmacol. 59 2 (2001) 170-176
30. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., and Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 5499 (2000) 2140-2144
31. Deng T., Shan S., Li Z.B., Wu Z.W., Liao C.Z., Ko B., Lu X.P., Cheng J., and Ning Z.Q. A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice. Biol. Pharm. Bull. 28 7 (2005) 1192-1196
32. Denson L.A., Sturm E., Echevarria W., Zimmerman T.L., Makishima M., Mangelsdorf D.J., and Karpen S.J. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121 1 (2001) 140-147
33. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
34. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 86 2 (2006) 465-514
35. Di-Poi N., Tan N.S., Michalik L., Wahli W., and Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10 4 (2002) 721-733
36. Dragnev K.H., Petty W.J., Shah S., Biddle A., Desai N.B., Memoli V., Rigas J.R., and Dmitrovsky E. Bexarotene and erlotinib for aerodigestive tract cancer. J. Clin. Oncol. 23 34 (2005) 8757-8764
37. Duvic M., Martin A.G., Kim Y., Olsen E., Wood G.S., Crowley C.A., and Yocum R.C. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch. Dermatol. 137 5 (2001) 581-593
38. Edwards P.A., Kast H.R., and Anisfeld A.M. BAREing it all: The adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid. Res. 43 1 (2002) 2-12
39. Egea P.F., Mitschler A., and Moras D. Molecular recognition of agonist ligands by RXRs. Mol. Endocrinol. 16 5 (2002) 987-997
40. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., and Desvergne B. Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142 10 (2001) 4195-4202
41. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., and Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24 9 (2003) 1541-1548
42. Feige J.N., Gelman L., Tudor C., Engelborghs Y., Wahli W., and Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 280 18 (2005) 17880-17890
43. Feige J.N., Gelman L., Michalik L., Desvergne B., and Wahli W. From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 45 2 (2006) 120-159
44. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., Han X., Gross R.W., Kozak R., Lopaschuk G.D., and Kelly D.P. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109 1 (2002) 121-130
45. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., and Kelly D.P. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc. Natl. Acad. Sci. USA 100 3 (2003) 1226-1231
46. Finck B.N., Bernal-Mizrachi C., Han D.H., Coleman T., Sambandam N., LaRiviere L.L., Holloszy J.O., Semenkovich C.F., and Kelly D.P. A potential link between muscle peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 1 2 (2005) 133-144
47. Francis G.A., Fayard E., Picard F., and Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65 (2003) 261-311
48. Gampe Jr. R.T., Montana V.G., Lambert M.H., Wisely G.B., Milburn M.V., and Xu H.E. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 14 17 (2000) 2229-2241
49. Gelman L., Michalik L., Desvergne B., and Wahli W. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors. Curr. Opin. Cell Biol. 17 2 (2005) 216-222
50. Germain P., Iyer J., Zechel C., and Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 6868 (2002) 187-192
51. Gernert D.L., Ajamie R., Ardecky R.A., Bell M.G., Leibowitz M.D., Mais D.A., Mapes C.M., Michellys P.Y., Rungta D., Reifel-Miller A., Tyhonas J.S., Yumibe N., et al. Design and synthesis of fluorinated RXR modulators. Bioorg. Med. Chem. Lett. 13 19 (2003) 3191-3195
52. Gernert D.L., Neel D.A., Boehm M.F., Leibowitz M.D., Mais D.A., Michellys P.Y., Rungta D., Reifel-Miller A., and Grese T.A. Design and synthesis of benzofused heterocyclic RXR modulators. Bioorg. Med. Chem. Lett. 14 11 (2004) 2759-2763
53. Goldstein J.T., Dobrzyn A., Clagett-Dame M., Pike J.W., and DeLuca H.F. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch. Biochem. Biophys. 420 1 (2003) 185-193
54. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 3 (2000) 517-526
55. Goodwin B., Watson M.A., Kim H., Miao J., Kemper J.K., and Kliewer S.A. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol. Endocrinol. 17 3 (2003) 386-394
56. Grefhorst A., Elzinga B.M., Voshol P.J., Plosch T., Kok T., Bloks V.W., van der Sluijs F.H., Havekes L.M., Romijn J.A., Verkade H.J., and Kuipers F. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277 37 (2002) 34182-34190
57. Grober J., Zaghini I., Fujii H., Jones S.A., Kliewer S.A., Willson T.M., Ono T., and Besnard P. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274 42 (1999) 29749-29754
58. Guan H.P., Li Y., Jensen M.V., Newgard C.B., Steppan C.M., and Lazar M.A. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8 10 (2002) 1122-1128
59. Gurnell M., Savage D.B., Chatterjee V.K., and O'Rahilly S. The metabolic syndrome: Peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J. Clin. Endocrinol. Metab. 88 6 (2003) 2412-2421
60. Haffner C.D., Lenhard J.M., Miller A.B., McDougald D.L., Dwornik K., Ittoop O.R., Gampe Jr. R.T., Xu H.E., Blanchard S., Montana V.G., Consler T.G., Bledsoe R., et al. Structure-based design of potent retinoid X receptor alpha agonists. J. Med. Chem. 47 8 (2004) 2010-2029
61. He W., Barak Y., Hevener A., Olson P., Liao D., Le J., Nelson M., Ong E., Olefsky J.M., and Evans R.M. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100 (2003) 15712-15717
62. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., and Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 2 (1992) 397-406
63. Holst D., Luquet S., Kristiansen K., and Grimaldi P.A. Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation. Exp. Cell Res. 288 1 (2003) 168-176
64. IJpenberg A., Tan N.S., Gelman L., Kersten S., Seydoux J., Xu J., Metzger D., Canaple L., Chambon P., Wahli W., and Desvergne B. In vivo activation of PPAR target genes by RXR homodimers. EMBO J. 23 10 (2004) 2083-2091
65. Imai T., Jiang M., Chambon P., and Metzger D. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA 98 1 (2001) 224-228
66. Imai T., Jiang M., Kastner P., Chambon P., and Metzger D. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl. Acad. Sci. USA 98 8 (2001) 4581-4586
67. Imai T., Takakuwa R., Marchand S., Dentz E., Bornert J.M., Messaddeq N., Wendling O., Mark M., Desvergne B., Wahli W., Chambon P., and Metzger D. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA 101 13 (2004) 4543-4547
68. Imai T., Takawuka R., Marchand S., Dentz E., Bornert J.-M., Messadedeq N., Wendling O., Mark M., Desvergne B., Wahli W., Chambon P., and Metzger D. PPAR gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA 101 (2004) 4543-4547
69. Jacobs C.M., and Paulsen R.E. Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B. Biochem. Biophys. Res. Commun. 336 2 (2005) 646-652
70. Jacobs M.N., Nolan G.T., and Hood S.R. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol. Appl. Pharmacol. 209 2 (2005) 123-133
71. Janowski B.A., Willy P.J., Devi T.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXRa. Nature 383 (1996) 728-731
72. Joseph S.B., Laffitte B.A., Patel P.H., Watson M.A., Matsukuma K.E., Walczak R., Collins J.L., Osborne T.F., and Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277 13 (2002) 11019-11025
73. Kassam A., Miao B., Young P.R., and Mukherjee R. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J. Biol. Chem. 278 12 (2003) 10028-10032
74. Kast H.R., Nguyen C.M., Sinal C.J., Jones S.A., Laffitte B.A., Reue K., Gonzalez F.J., Willson T.M., and Edwards P.A. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: A molecular mechanism linking plasma triglyceride levels to bile acids. Mol. Endocrinol. 15 10 (2001) 1720-1728
75. Kastner P., Grondona J.M., Mark M., Gansmuller A., LeMeur M., Decimo D., Vonesch J.-L., Dollé P., and Chambon P. Genetic analysis of RXRa developmental function: Convergence of RXR and RAR signalling pathways in heart and eye morphogenesis. Cell 78 (1994) 987-1003
76. Kersten S., Kelleher D., Chambon P., Gronemeyer H., and Noy N. Retinoid X receptor α forms tetramers in solution. Proc. Natl. Acad. Sci. USA 92 (1995) 8645-8649
77. Kersten S., Dong D., Lee W., Reczek P.R., and Noy N. Auto-silencing by the retinoid X receptor. J. Mol. Biol. 284 1 (1998) 21-32
78. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
79. Kitareewan S., Burka L.T., Tomer K.B., Parker C.E., Deterding L.J., Stevens R.D., Forman B.M., Mais D.E., Heyman R.A., McMorris T., and Weinberger C. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell 7 8 (1996) 1153-1166
80. Kramer D.K., Al-Khalili L., Perrini S., Skogsberg J., Wretenberg P., Kannisto K., Wallberg-Henriksson H., Ehrenborg E., Zierath J.R., and Krook A. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 54 4 (2005) 1157-1163
81. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ishii C., Sugiyama T., Eto K., Tsubamoto Y., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4 4 (1999) 597-609
82. Kullak-Ublick G.A., Stieger B., and Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126 1 (2004) 322-342
83. Lee C.H., Olson P., Hevener A., Mehl I., Chong L.W., Olefsky J.M., Gonzalez F.J., Ham J., Kang H., Peters J.M., and Evans R.M. PPARdelta regulates glucose metabolism and insulin sensitivity. Proc. Natl. Acad. Sci. USA 103 9 (2006) 3444-3449
84. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
85. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 6 (1997) 3137-3140
86. Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Bergera J., Cullinan C.A., Sparrow C.P., Baffic J., Berger G.D., Santini C., Marquis R.W., et al. Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett. 473 3 (2000) 333-336
87. Leibowitz M.D., Ardecky R.J., Boehm M.F., Broderick C.L., Carfagna M.A., Crombie D.L., D′Arrigo J., Etgen G.J., Faul M.M., Grese T.A., Havel H., Hein N., et al. Biological characterization of a heterodimer-selective retinoid X receptor modulator: Potential benefits for the treatment of type 2 diabetes. Endocrinology 147 2 (2006) 1044-1053
88. Lemotte P.K., Keidel S., and Apfel C.M. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236 (1996) 328-333
89. Lengqvist J., Mata De Urquiza A., Bergman A.C., Willson T.M., Sjovall J., Perlmann T., and Griffiths W.J. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics 3 7 (2004) 692-703
90. Leone T., Weinheimer C., and Kelly D. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
91. Li D., Yamada T., Wang F., Vulin A.I., and Samuels H.H. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer. J. Biol. Chem. 279 9 (2004) 7427-7437
92. Liu S., Ogilvie K.M., Klausing K., Lawson M.A., Jolley D., Li D., Bilakovics J., Pascual B., Hein N., Urcan M., and Leibowitz M.D. Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology 143 8 (2002) 2880-2885
93. Lu J., Cistola D.P., and Li E. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance. Biochemistry 45 6 (2006) 1629-1639
94. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., and Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6 3 (2000) 507-515
95. Luptak I., Balschi J.A., Xing Y., Leone T.C., Kelly D.P., and Tian R. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 112 15 (2005) 2339-2346
96. Luquet S., Lopez-Soriano J., Holst D., Fredenrich A., Melki J., Rassoulzadegan M., and Grimaldi P.A. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 17 15 (2003) 2299-2301
97. Luria A., and Furlow J.D. Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos. Proc. Natl. Acad. Sci. USA 101 24 (2004) 8987-8992
98. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., and Shan B. Identification of a nuclear receptor for bile acids. Science 284 5418 (1999) 1362-1365
99. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 6 (1995) 841-850
100. Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., and Evans R.M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6 3 (1992) 329-344
101. Mark M., Ghyselinck N.B., Wendling O., Dupe V., Mascrez B., Kastner P., and Chambon P. A genetic dissection of the retinoid signalling pathway in the mouse. Proc. Nutr. Soc. 58 3 (1999) 609-613
102. Mark M., Ghyselinck N.B., and Chambon P. Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 451-480
103. Mascrez B., Mark M., Dierich A., Ghyselinck N., Kastner P., and Chambon P. The RXRα ligand-dependent activation function (AF-2) is important for mouse development. Development 125 (1998) 4691-4707
104. Mayerson A.B., Hundal R.S., Dufour S., Lebon V., Befroy D., Cline G.W., Enocksson S., Inzucchi S.E., Shulman G.I., and Petersen K.F. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51 3 (2002) 797-802
105. Mehta K., McQueen T., Neamati N., Collins S., and Andreeff M. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ. 7 2 (1996) 179-186
106. Mertz J.R., Shang E., Piantedosi R., Wei S., Wolgemuth D.J., and Blaner W.S. Identification and characterization of a stereospecific human enzyme that catalyzes 9-cis-retinol oxidation. A possible role in 9-cis-retinoic acid formation. J. Biol. Chem. 272 18 (1997) 11744-11749
107. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J., Metzger D., Chambon P., et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J. Cell Biol. 154 4 (2001) 799-814
108. Michalik L., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors beta/delta: Emerging roles for a previously neglected third family member. Curr. Opin. Lipidol. 14 2 (2003) 129-135
109. Michalik L., Desvergne B., and Wahli W. Peroxisome-proliferator-activated receptors and cancers: Complex stories. Nat. Rev. Cancer 4 1 (2004) 61-70
110. Michellys P.Y., Ardecky R.J., Chen J.H., Crombie D.L., Etgen G.J., Faul M.M., Faulkner A.L., Grese T.A., Heyman R.A., Karanewsky D.S., Klausing K., Leibowitz M.D., et al. Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. J. Med. Chem. 46 13 (2003) 2683-2696
111. Michellys P.Y., Boehm M.F., Chen J.H., Grese T.A., Karanewsky D.S., Leibowitz M.D., Liu S., Mais D.A., Mapes C.M., Reifel-Miller A., Ogilvie K.M., Rungta D., et al. Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. Bioorg. Med. Chem. Lett. 13 22 (2003) 4071-4075
112. Miles P.D., Barak Y., He W., Evans R.M., and Olefsky J.M. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J. Clin. Invest. 105 3 (2000) 287-292
113. Miller V.A., Benedetti F.M., Rigas J.R., Verret A.L., Pfister D.G., Straus D., Kris M.G., Crisp M., Heyman R., Loewen G.R., Truglia J.A., and Warrell Jr. R.P. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J. Clin. Oncol. 15 2 (1997) 790-795
114. Minucci S., and Ozato K. Retinoid receptors in transcriptional regulation. Curr. Opin. Genet. Dev. 6 (1996) 567-574
115. Mukherjee R., Davies P.J.A., Cromble D.L., Bischoff E.D., Cesario R.M., Jow L., Hamann L.G., Boehm M.F., Mondon C.E., Nadzan A.M., Paterniti Jr. J.R., and Heyman R.A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386 (1997) 407-410
116. Mukherjee R., Strasser J., Jow L., Hoener P., Paterniti Jr. J.R., and Heyman R.A. RXR agonists activate PPARα-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler. Thromb. Vasc. Biol. 18 2 (1998) 272-276
117. Muoio D.M., MacLean P.S., Lang D.B., Li S., Houmard J.A., Way J.M., Winegar D.A., Corton J.C., Dohm G.L., and Kraus W.E. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277 29 (2002) 26089-26097
118. Nadra K., Anghel S.I., Joye E., Tan N.S., Basu-Modak S., Trono D., Wahli W., and Desvergne B. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol. Cell. Biol. 26 8 (2006) 3266-3281
119. Nagy L., Thomazy V.A., Shipley G.L., Fesus L., Lamph W., Heyman R.A., Chandraratna R.A.S., and Davies P.J.A. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15 (1995) 3540-3551
120. Nettles K.W., and Greene G.L. Ligand control of coregulator recruitment to nuclear receptors. Annu. Rev. Physiol. 67 (2005) 309-333
121. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 97 (1999) 161-163
122. Oakes N.D., Camilleri S., Furler S.M., Chisholm D.J., and Kraegen E.W. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 46 8 (1997) 935-942
123. Oliver Jr. W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., Lewis M.C., Winegar D.A., Sznaidman M.L., Lambert M.H., Xu H.E., Sternbach D.D., et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98 9 (2001) 5306-5311
124. Ouamrane L., Larrieu G., Gauthier B., and Pineau T. RXR activators molecular signalling: Involvement of a PPARalpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart. Br. J. Pharmacol. 138 5 (2003) 845-854
125. Park C.W., Zhang Y., Zhang X., Wu J., Chen L., Cha D.R., Su D., Hwang M.T., Fan X., Davis L., Striker G., Zheng F., et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int. 69 9 (2006) 1511-1517
126. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., and Lehmann J.M. Bile acids: Natural ligands for an orphan nuclear receptor. Science 284 5418 (1999) 1365-1368
127. Patel D.D., Knight B.L., Wiggins D., Humphreys S.M., and Gibbons G.F. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice. J. Lipid Res. 42 3 (2001) 328-337
128. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.M., Hammer R.E., and Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93 5 (1998) 693-704
129. Plosch T., Kok T., Bloks V.W., Smit M.J., Havinga R., Chimini G., Groen A.K., and Kuipers F. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J. Biol. Chem. 277 37 (2002) 33870-33877
130. Prufer K., and Barsony J. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol. Endocrinol. 16 8 (2002) 1738-1751
131. Repa J.J., and Mangelsdorf D.J. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotechnol. 10 6 (1999) 557-563
132. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., Shan B., Brown M.S., Goldstein J.L., and Mangelsdorf D.J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 22 (2000) 2819-2830
133. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., and Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 5484 (2000) 1524-1529
134. Repa J.J., Berge K.E., Pomajzl C., Richardson J.A., Hobbs H., and Mangelsdorf D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277 21 (2002) 18793-18800
135. Rieusset J., Touri F., Michalik L., Escher P., Desvergne B., Niesor E., and Wahli W. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Mol. Endocrinol. 16 11 (2002) 2628-2644
136. Rizvi N.A., Marshall J.L., Dahut W., Ness E., Truglia J.A., Loewen G., Gill G.M., Ulm E.H., Geiser R., Jaunakais D., and Hawkins M.J. A Phase I study of LGD1069 in adults with advanced cancer. Clin. Cancer Res. 5 7 (1999) 1658-1664
137. Romert A., Tuvendal P., Simon A., Dencker L., and Eriksson U. The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid. Proc. Natl. Acad. Sci. USA 95 8 (1998) 4404-4409
138. Rosen E.D., and Spiegelman B.M. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276 41 (2001) 37731-37734
139. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., and Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4 4 (1999) 611-617
140. Schuetz E.G., Strom S., Yasuda K., Lecureur V., Assem M., Brimer C., Lamba J., Kim R.B., Ramachandran V., Komoroski B.J., Venkataramanan R., Cai H., et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 276 42 (2001) 39411-39418
141. Schulman I.G., Shao G., and Heyman R.A. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: Intermolecular synergy requires only the PPARgamma hormone-dependent activation function. Mol. Cell. Biol. 18 6 (1998) 3483-3494
142. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14 22 (2000) 2831-2838
143. Seol W., Choi H.S., and Moore D.D. Isolation of proteins that interact specifically with the retinoid X receptor: Two novel orphan receptors. Mol. Endocrinol. 9 1 (1995) 72-85
144. Shao J., Sheng H., and DuBois R.N. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 62 11 (2002) 3282-3288
145. Sharma V., Hays W.R., Wood W.M., Pugazhenthi U., St Germain D.L., Bianco A.C., Krezel W., Chambon P., and Haugen B.R. Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology 147 3 (2006) 1438-1451
146. Shen Q., Cline G.W., Shulman G.I., Leibowitz M.D., and Davies P.J. Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice. J. Biol. Chem. 279 19 (2004) 19721-19731
147. Shulman A.I., Larson C., Mangelsdorf D.J., and Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116 3 (2004) 417-429
148. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., and Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102 6 (2000) 731-744
149. Singh Ahuja H., Liu S., Crombie D.L., Boehm M., Leibowitz M.D., Heyman R.A., Depre C., Nagy L., Tontonoz P., and Davies P.J. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol. Pharmacol. 59 4 (2001) 765-773
150. Solomin L., Johansson C.B., Zetterstrom R.H., Bissonnette R.P., Heyman R.A., Olson L., Lendahl U., Frisen J., and Perlmann T. Retinoid-X receptor signalling in the developing spinal cord. Nature 395 6700 (1998) 398-402
151. Sucov H.M., Dyson E., Gumeringer C.L., Price J., Chien K.R., and Evans R.M. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8 9 (1994) 1007-1018
152. Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P., Cherkaoui-Malki M., Qi C., Zhu Y.J., Rao M.S., and Reddy J.K. Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc. Natl. Acad. Sci. USA 99 18 (2002) 11836-11841
153. Szanto A., Benko S., Szatmari I., Balint B.L., Furtos I., Ruhl R., Molnar S., Csiba L., Garuti R., Calandra S., Larsson H., Diczfalusy U., et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol. 24 18 (2004) 8154-8166
154. Szanto A., Narkar V., Shen Q., Uray I.P., Davies P.J., and Nagy L. Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ. 11 Suppl. 2 (2004) S126-S143
155. Tall A.R., Costet P., and Wang N. Regulation and mechanisms of macrophage cholesterol efflux. J. Clin. Invest. 110 7 (2002) 899-904
156. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R.X., Tachibana K., Watanabe Y., Uchiyama Y., et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100 26 (2003) 15924-15929
157. Toma S., Isnardi L., Riccardi L., and Bollag W. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids. Anticancer. Res. 18 2A (1998) 935-942
158. Tontonoz P., and Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 6 (2003) 985-993
159. Tsai C.C., and Fondell J.D. Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam. Horm. 68 (2004) 93-122
160. Tudor C., Feige J.N., Pingali H., Bhushan Lohray V., Wahli W., Desvergne B., Engelborghs Y., and Gelman L. Association with coregulators is the major determinant governing PPAR mobility in living cells. J. Biol. Chem. (2006) (in press)
161. Tzameli I., Chua S.S., Cheskis B., and Moore D.D. Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR. Nucl. Recept. 1 1 (2003) 2
162. Urizar N.L., Dowhan D.H., and Moore D.D. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275 50 (2000) 39313-39317
163. van der Veen J.N., Kruit J.K., Havinga R., Baller J.F., Chimini G., Lestavel S., Staels B., Groot P.H., Groen A.K., and Kuipers F. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J. Lipid Res. 46 3 (2005) 526-534
164. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr. Rev. 21 6 (2000) 697-738
165. Wan Y.J., An D., Cai Y., Repa J.J., Hung-Po Chen T., Flores M., Postic C., Magnuson M.A., Chen J., Chien K.R., French S., Mangelsdorf D.J., et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 20 12 (2000) 4436-4444
166. Wan Y.J., Cai Y., Lungo W., Fu P., Locker J., French S., and Sucov H.M. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J. Biol. Chem. 275 36 (2000) 28285-28290
167. Wang H., Chen J., Hollister K., Sowers L.C., and Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3 5 (1999) 543-553
168. Wang Y., Yao R., Maciag A., Grubbs C.J., Lubet R.A., and You M. Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide. Mol. Cancer Ther. 5 4 (2006) 1060-1072
169. Wang Y.X., Lee C.H., Tiep S., Yu R.T., Ham J., Kang H., and Evans R.M. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113 2 (2003) 159-170
170. Wang Y.X., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., Ham J., Kang H., and Evans R.M. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2 10 (2004) e294
171. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P., and Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423 6939 (2003) 555-560
172. Wendling O., Chambon P., and Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. USA 96 2 (1999) 547-551
173. Xie W., Barwick J.L., Simon C.M., Pierce A.M., Safe S., Blumberg B., Guzelian P.S., and Evans R.M. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14 23 (2000) 3014-3023
174. Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B., Collins J.L., Oplinger J.A., Kliewer S.A., Gampe Jr. R.T., McKee D.D., Moore J.T., and Willson T.M. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 98 24 (2001) 13919-13924
175. Yasmin R., Yeung K.T., Chung R.H., Gaczynska M.E., Osmulski P.A., and Noy N. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance". J. Mol. Biol. 343 2 (2004) 327-338
176. Yasmin R., Williams R.M., Xu M., and Noy N. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J. Biol. Chem. 280 48 (2005) 40152-40160
177. Yechoor V.K., Patti M.E., Saccone R., and Kahn C.R. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc. Natl. Acad. Sci. USA 99 16 (2002) 10587-10592
178. Zhang X.K., Lehmann J., Hoffmann B., Dawson M.I., Cameron J., Graupner G., Hermann T., Tran P., and Pfahl M. Homodimer formation of retinoid X-Receptor induced by 9-cis retinoic acid. Nature 358 (1992) 587-591